Dynamic Technology Lab Private LTD Castle Biosciences Inc Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $288,910 - $409,195	-8,710 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $340,212 - $588,621	8,710 New	8,710 $373,000
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $188,808 - $243,663	-3,140 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$50.07 - $76.78 $157,219 - $241,089	3,140 New	3,140 $230,000
Q4 2020 Feb 11, 2021	SELL	$43.6 - $73.05 $199,295 - $333,911	-4,571 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$38.47 - $52.03 $175,846 - $237,829	4,571 New	4,571 $235,000
Q2 2020 Aug 14, 2020	SELL	$27.28 - $43.01 $308,591 - $486,529	-11,312 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$23.08 - $35.53 $261,080 - $401,915	11,312 New	11,312 $337,000

171

25.5M

511K

130K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $750M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.